Although myeloid‐cell RGS2 knockout does not affect Ang II–induced hypertension/organ damage in mice, high RGS2 in Gitelman/Bartter syndromes—human models of endogenous Ang II signaling antagonism—is associated with hypotensive/antiremodeling effects

Lorenzo A Calò, Martina Cacciapuoti, Paul A Davis · 2026

Read Although myeloid‐cell RGS2 knockout does not affect Ang II–induced hypertension/organ damage in mice, high RGS2 in Gitelman/Bartter syndromes—human models of endogenous Ang II signaling antagonism—is associated with hypotensive/antiremodeling effects by Lorenzo A Calò, Martina Cacciapuoti, Paul A Davis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591543.txt.

Description

Lorenzo Calò, Martina Cacciapuoti, and Paul Davis discuss a puzzle about blood pressure control in this 2026 article. A protein called RGS2 puts a brake on the hormone system that raises blood pressure, and it is found in large amounts in immune cells of the blood vessel wall. A mouse study they review removed that brake from those cells only, yet the mice showed no extra harm when given the hormone.

The authors set the mouse result beside rare human illnesses, Gitelman and Bartter syndromes, where the same hormone system is naturally blunted. In those patients, high levels of the protein go with low pressure and less vessel damage. The contrast suggests that the protein's effect depends on the cell type and the whole body setting, not on immune cells alone.

Catalog record

CREATORLorenzo A Calò, Martina Cacciapuoti, Paul A Davis
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE4 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13591543

Browse the full library · About the Tower of Babel